KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Coherent (COHR) Research & Development (2016 - 2025)

Coherent's Research & Development history spans 17 years, with the latest figure at $165.7 million for Q4 2025.

  • For Q4 2025, Research & Development rose 15.19% year-over-year to $165.7 million; the TTM value through Dec 2025 reached $627.1 million, up 18.4%, while the annual FY2025 figure was $581.9 million, 21.54% up from the prior year.
  • Research & Development for Q4 2025 was $165.7 million at Coherent, up from $154.9 million in the prior quarter.
  • Across five years, Research & Development topped out at $165.7 million in Q4 2025 and bottomed at $83.2 million in Q1 2021.
  • The 5-year median for Research & Development is $124.9 million (2023), against an average of $121.3 million.
  • The largest annual shift saw Research & Development decreased 16.64% in 2021 before it surged 36.1% in 2022.
  • A 5-year view of Research & Development shows it stood at $95.3 million in 2021, then soared by 35.1% to $128.8 million in 2022, then dropped by 13.69% to $111.2 million in 2023, then increased by 29.41% to $143.9 million in 2024, then increased by 15.19% to $165.7 million in 2025.
  • Per Business Quant, the three most recent readings for COHR's Research & Development are $165.7 million (Q4 2025), $154.9 million (Q3 2025), and $155.7 million (Q2 2025).